Immune responses to an inactive vaccine against American cutaneous leishmaniasis together with granulocyte-macrophage colony-stimulating factor

This publication has 18 references indexed in Scilit:

• Phase 1 Study of an Inactivated Vaccine against American Tegumentary Leishmaniasis in Normal Volunteers in Brazil
  Memórias do Instituto Oswaldo Cruz, 1998
• Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine
  Vaccine, 1996
• Evidence of a T helper type 2 activation in human schistosomiasis
  European Journal of Immunology, 1996
• Evaluation of the efficacy of Iran leishmanin and comparison with leishmanins from Wellcome (UK) and Roma (Italy) in cured cutaneous leishmaniasis patients
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1993
• The clinical and immunological spectrum of American cutaneous leishmaniasis
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1993
• Induction and modulation of the immune response to Leishmania by Montenegro's skin test
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1993
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
  The Journal of Experimental Medicine, 1991
• Granulocyte-Macrophage and Macrophage Colony-Stimulating Factors Activate Intramacrophage Killing of Leishmania mexicana amazonensis
  The Journal of Infectious Diseases, 1990
• Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages.
  The Journal of Experimental Medicine, 1987
• A field trial of a vaccine against American dermal leishmaniasis
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1979